“THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES: Targeted Next-Generation Sequencing Usage in Cytogenetically Normal Myeloid Malignancies”. (2020) 2021. Mediterranean Journal of Hematology and Infectious Diseases 13 (1): e2021013. https://doi.org/10.4084/mjhid.2021.013.